Bahl & Gaynor
Bahl & Gaynor reported 341 stocks worth $21.7B in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are AVGO (4.5%), LLY (3.6%) and MSFT (3.1%). Compared with Q1 2026, the fund opened new positions in XOM, TKO and VTR, added to TSM, UNH and PNC, trimmed AVGO, LLY and MSFT and sold out of XOM, OSK and TSCO.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  AVGO Broadcom Inc | $986M | 4.5% | 2.6M | −225K (−8%) | 8 of 8 | |
| 2 |  LLY Eli Lilly & Co | $787M | 3.6% | 656K | −10K (−2%) | 8 of 8 | |
| 3 |  MSFT Microsoft Corp | $676M | 3.1% | 1.8M | −59K (−3%) | 8 of 8 | |
| 4 |  TSM Taiwan Semiconductor Mfg Ltd | $671M | 3.1% | 1.4M | +50K (+4%) | 8 of 8 | |
| 5 |  ABBV Abbvie Inc | $652M | 3.0% | 2.6M | −146K (−5%) | 8 of 8 | |
| 6 |  JPM Jpmorgan Chase & Co. | $625M | 2.9% | 1.9M | −20K (−1%) | 8 of 8 | |
| 7 |  WMB Williams Cos Inc | $503M | 2.3% | 6.8M | −88K (−1%) | 8 of 8 | |
| 8 |  JNJ Johnson & Johnson | $501M | 2.3% | 2M | −750K (−28%) | 8 of 8 | |
| 9 |  PG Procter & Gamble Co | $476M | 2.2% | 3.2M | −63K (−2%) | 8 of 8 | |
| 10 |  UNH Unitedhealth Group Inc | $475M | 2.2% | 1.1M | +291K (+34%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 XOM Exxon Mobil Corp | $248M | 1.5M |
HONEYWELL INTL INC | $27.1M | 120K |
 OSK Oshkosh Corp | $8.5M | 58K |
 TSCO Tractor Supply Co | $7.9M | 174K |
CSG SYS INTL INC | $597K | 7,463 |
🔒 Free account: see all 10.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 13, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Bahl & Gaynor 13F FAQ
What does Bahl & Gaynor own?
Bahl & Gaynor reported 341 stocks worth $21.7B in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are AVGO (4.5%), LLY (3.6%) and MSFT (3.1%). The table above lists every position in the filing (the top 10 without an account).
What did Bahl & Gaynor buy and sell in Q2 2026?
Compared with Q1 2026: 24 new positions, 86 added to, 182 trimmed and 10 sold out. New positions include XOM, TKO and VTR. It sold all of XOM, OSK and TSCO.
When will Bahl & Gaynor file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Bahl & Gaynor's portfolio worth?
The Q2 2026 filing reports $21.7B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.